Medical’s Silk Thanks, and us Lynn. fourth call. you everyone Road and for earnings afternoon for Good XXXX quarter thank joining full-year
Financial Buchanan, me Officer. our Lucas Chief is Joining
outcomes patient adoption consistent growth. and robust XXXX revenue marked that compelling and TCAR drove was by continued
fourth quarter of million, Our revenue $XX.X year growth $XX.X full of was results XX% with million year-over-year, and up over XX%.
our year, exceptionally substantial I key the said of beginning base progress the and the of two commercial evidence throughout in clinical proud execution. priorities XXXX am we building many we team’s towards made U.S. as the accomplishments
we June, of In CEA. TCAR our X XX,XXX patients results final the over well announced study as standard ROADSTER the endarterectomy, Surveillance TCAR as compared results Project, of or from post-market carotid to care which the in favorably updated
a benefits the to standard the the December, our U.S. These and published of In showing studies goal our Association carotid second provided execution. a of stenting care artery of JAMA, of contributed TCAR significant Journal over Commercial compelling becoming or large transfemoral priority of CAS. American Medical towards key datasets tailwind or
XX reach total year territories our approximately base hospital our to physicians physicians expanded new trained ee beginning XX to XXX accounts. in And year-end. This team of to from account XXX sales we from XXX over the approximately XXXX, In at the at trained. turn XXXX expanded approximately
enabled which having by quarter, our based and year-end. TCAR the XX,XXX physician In performed procedures, to the XXXX with us mark procedures procedure XXXX over the cross fourth cumulative growing performed end approximately year been
Last years a retired he one on to resolved right further some treatment his I difficulty Vascular like but milestones a spontaneously, Wilson goals diagnosed TCAR for Wayne unexpectedly would and is from year, thoughts CEA Dr. Surgeon having after evaluation, to turning was XXXX, side share artery journey. carotid few after Virginia. Before patient aphasia experienced left received speaking, it he earlier. or on with disease Roanoke,
side, TCAR that procedure anatomic [inaudible] due the complications. would of Clinic his age for and Carilion his features risk Dr. increase and surgical Adams from to the right the recommended to
such that would diabetes, including comorbidities failure, be several has risky. he addition, general artery In anesthesia and heart coronary disease,
was self-described at TCAR Surgery Medical vascular the him benefits and and was University to of have Adams the Wayne he and for he’d a consideration. Virginia the of the Center Dr. surgeon, and Chief the about after initially bit reluctant hearing walked procedure. Wayne school been of was through time, careful a TCAR old first agreed
history After under his was TCAR CEA receiving CEA the was procedure successful past. Wayne poignant to local his given and everyday This a particularly as patient activities experience own a anesthesia, normal back quickly. performing in Wayne’s of
for daughter faster quality all his time his recovery Dr. improvement life. Wilson, his expressed of appreciation in and the wife, and profound
recover quickly to building the the rest time and TCAR, people most. and when we Road love disease allowing to Following spending one safely potentially minimally invasive reducing and story of reduce stroke Silk this other artery At they at effectively devastating TCAR. a risk with Wayne demonstrates comes the carotid return and positive time. of the while physician a TCAR the and specifically approach how complications with treat patient patients risk Medical, never to can power experiences of one it
underpinned continue Looking to we trained and now Commercial in ahead driving to physician focused on are our much be by base penetration clinical larger U.S. deeper execution XXXX, evidence base.
full-year for $XX revenues range to XXXX in be million the to $XX of are expectations million. Our
disease, the As priorities for leader carotid work to we’ve becoming we in outlined three the continue treatment XXXX. towards global artery of strategic
standard our finally, Commercial and label U.S. of and a goal of reimbursement execution. expansion development patient outlining three, risk obtaining R&D number Number the for pipeline. coverage regulatory population. further one, pathway surgical our two, Number with And
our U.S. XXXX. biggest with most for and Starting important priority execution, Commercial
in the and in and operational nature. our both discussed we success measuring performance are metrics key we As several near through initiatives past, long-term and
in which us long-term of always, and dictated of on on outcomes levers becoming will and business pace by our the our focus activation, This key excellence. will well is As path patient our the account focus of training, always the put we and new physician goal be expansion, towards operational standard working team execute best commercial the care.
organization. the adoption U.S. increased by our supported our expect trained to TCAR expanded will in come continue growing base physician We growth commercial from by
have people with our combined world of training rolled Over in methodically our we a patient which physician carefully technology the been success years, that field programs and TCAR, It last class driving success. led and fuels as turn has to and team hiring with is our positive outcomes we’ve TCAR. commercial out couple our
about of in still commercial In generate orders where TCAR is XXXX, TCAR products driving initial hospitals to all our the adoption execution and is repeat performed. of
their the we train believe which to accounts, We new and to are is curve, early continue we in of continuing critical learning hospital growing to in and long-term. significant established new physicians both provide in TCAR support sustain and adoption
adoption capturing a year would moving thereby receive larger continue this focus to up patients, CEA who already share primary our However, is the CAS. otherwise trained or physicians curve,
have Many of of their significant upside and others TCAR are have potential. physicians trained our still to but in still adopted levels, early lots experience,
to physician business a patient time, one every continues be Our at each at a one time day. and
increase data XXXX, size for a courses. we heels the half demand number and the physician to meaningful presentations in our test and On the our of of training courses increased in and drive saw second publications throughout of interest We responded this XXXX.
to increasing where the outcomes successful Our train patient at and confidence which the can adoption feel positive curve, in sustain sustained required experiences engender we is philosophy and early for a the we adoption over pace long-term. physicians
a certified periods and certification the before trained physicians result, small that of trained includes year the and in we initially the for cohort fellows XXXX year, XXX over a of physicians As official
approximately year. would physicians, XXX our plan base the XXXX, the end to new In we approximately which to total physician XXXX train bring by trained of
two carotid with We that continue to of ratio believe procedures drive bulk majority approximately a cover to that hospitals between and the of XX effectively and to physicians can we territories of one area the a XX
managers specialists. development to therapy
Throughout we year. goal plan XXXX, for XX,XXX team our exit base have yield our set in XX a procedures selectively qualified for excess expect efficient organization. the commercial commercial And highly to with trained of we year personnel territories. roughly to and the add physician to to We
indication ENROUTE surgical Moving to reimbursement. stent priority, for standard the second our and to expanding the broadening patients risk key
reimbursement treated eligible the deemed We that this is two-thirds considered standard for TCAR patients patients approximately As of who Surveillance risk. also events the reminder, the population current high highest a surgical the for And risk. in population for or with the represents at of remaining is indication for quick stent currently in patients CEA ENROUTE surgical are from risk high risk adverse estimate the use Project. the
a represented in shown patients sicker successful achieve the higher to the future ability standard clear outcomes We’ve patient risk which older in the and we in of population, surgical adoption well surgical drive for risk patients. TCAR bodes believe
Vascular FDA, and combined CMS with our of and Society finalize we reimbursement the on surgical continued XXXX. risk our provide Through patients expect standard Surgery, pathways in for clarity regulatory to key and a constituents, collaboration
adoption. to approach is what required, will providing discussions and widespread the ultimately pathway surgical the is look We standard have meet further to the risk needs right is on been regular and obtain forward We with during all support in our physician we clarity desired, what year. as what what stakeholder updates on stakeholders
third our development. on pipeline priority focused Finally, continued is
and We generation meet are the patients. additional TCAR their continued support and to committed improve physicians of to needs the and products to development evolving next of
First to increase continued to TCAR ease, to products by developing iterating and and products. of ways adoption continue and support convenience improve seek foremost, the existing procedure potentially we per will and to opportunity revenue speed, new the
our physiologic vascular arch are broad a and both Neuroprotection, and advantages and procedures direct expertise heart, carotid core possible and disease brain. the competencies in leveraging in targeting by access platform in of development trans states carotid with the new approach we and intellectual Further, the and made engineering property our products aortic
where strategies therapies we’re ischemic future. about other acute areas forward to clinical Transcarotid needs unmet potential stroke our in products areas. pipeline on are and about and progress we details And more remain. sharing the These look the We our believe for significant excited and
In market, still summary, where us. in U.S. we core TCAR substantial growth performance front and opportunity expect market in have we of our
continue longer progress growth we term initiatives. to other our While working
unmet are opportunities and to delivering develop We by improve clinical we solutions. entire excited committed the outcomes patient out platform and are new across to seeking working our needs about
call Buchanan, will over Financial now to our Chief Lucas Officer. With the that, I turn
